In this review:
Healthy eating patterns and CV disease risk
Arterial calcification at multiple sites: sex-specific CV risk profiles
Invasive vs non-invasive management of non-STEMI in older patients
Impact of COVID-19 pandemic on admission rates for ACS in England
SGLT2 inhibitors in patients with HFrEF
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy
Subcutaneous vs transvenous defibrillator therapy
Opportunistic screening vs usual care for detection of AF in primary care
Aspirin ± clopidogrel after TAVI
Benefits of early rhythm-control therapy in patients with AF
Please login below to download this issue (PDF)